James Rosen serves as Executive at APPLIED GENETIC TECHNOLOGIES CORP, where they oversee executive responsibilities. Since joining the company, James Rosen has executed 4 insider transactions totaling $757.8K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 30, 2022 involved transacting 1,000 shares valued at $0.
James Rosen currently holds 1,000 shares of APPLIED GENETIC TECHNOLOGIES CORP (AGTC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James Rosen has been a net buyer of AGTC stock. They have purchased $757.8K and sold $0 worth of shares.
James Rosen's most recent insider trade was on Nov 30, 2022, when they sold 1,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $3.38 |
| Discretionary |
| Apr 1, 2014 | AGTC | $0 | Conversion | 1,142,666 | $N/A | Discretionary |
| Apr 1, 2014 | AGTC | $754.5K | Purchase | 62,871 | $12.00 | Discretionary |